Alimera Sciences – ALIM – Expects to Begin Generating Revenue in the First Quarter of 2013
Alimera Sciences, Inc. (Nasdaq:ALIM), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced financial results for the second quarter ended June 30, 2012. Alimera believes that it...